Table 3 Possible sources of heterogeneity: meta-regressions
|  | Standard of Diagnosis | WHtR cut-off | ||||
|---|---|---|---|---|---|---|
Outcome | χ2 | P | I2 | χ2 | P | I2 |
CMR3 | NA | NA | NA | 298.64 |  < 0.001 | 99 (99–100) |
CMR2 | NA | NA | NA | 54.92 |  < 0.001 | 96 (94–99) |
CMR1 | NA | NA | NA | 6.51 | 0.04 | 69 (31–100) |
Elevated FBG | 2.59 | 0.27 | 23 (0–100) | 19.03 |  < 0.001 | 89 (79–100) |
Elevated BP | 1.46 | 0.48 | 0 (0–100) | 169.46 |  < 0.001 | 99 (98–99) |
Dyslipidaemia | NA | NA | NA | 40.33 |  < 0.001 | 95 (91–99) |
Elevated TG | 2.84 | 0.24 | 30 (0–100) | 6.7 | 0.04 | 70 (33–100) |
Low HDL-C | 3.05 | 0.22 | 35 (0–100) | 9.89 | 0.01 | 80 (56–100) |
Central obesity | 1.77 | 0.47 | 0 (0–100) | 1.34 | 0.51 | 0 (0–100) |